Exicure Announces Co-Development Agreement with Adbiotech for Burixafor (GPC-100)
Exicure, Inc. announced a co-development agreement with Adbiotech Co., Ltd. to explore combination therapies using Burixafor (GPC-100). The collaborat...
XCUR
--
--
--
--
Price Chart (30 Days)
Ad Space
Analyst Sentiment
Bullish (1)
Neutral (0)
Bearish (0)
Latest XCUR News
Research XCUR on:
Ad Space